Search Results

Chlorogenic acid attenuates cardiac hypertrophy and fibrosis by downregulating galectin 3.

• Authors : Kim SH; Department of Cardiology, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju, 61469, Republic of Korea.; Department of Biomedical Sciences, Graduate School of Chonnam National University, Hwasun, 58128, Republic of Korea.

Subjects: Chlorogenic Acid*/Chlorogenic Acid*/Chlorogenic Acid*/pharmacology ; Cardiomegaly*/Cardiomegaly*/Cardiomegaly*/drug therapy ; Cardiomegaly*/Cardiomegaly*/Cardiomegaly*/metabolism

• Source: Scientific reports [Sci Rep] 2025 Jul 24; Vol. 15 (1), pp. 26925. Date of Electronic Publication: 2025 Jul 24.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Myoblast-Derived Galectin 3 Impairs the Early Phases of Osteogenesis Affecting Notch and Akt Activity.

• Authors : Amore E; Laboratorio Ramses, IRCCS Istituto Ortopedico Rizzoli, Via di Barbiano 1/10, 40136 Bologna, Italy.; Cenni V

Subjects: Cell Differentiation* ; Galectin 3*/Galectin 3*/Galectin 3*/metabolism ; Galectin 3*/Galectin 3*/Galectin 3*/genetics

• Source: Biomolecules [Biomolecules] 2024 Sep 30; Vol. 14 (10). Date of Electronic Publication: 2024 Sep 30.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium: Internet ISSN: 2218-273X

Record details

Targeting Galectin 3 illuminates its contributions to the pathology of uterine serous carcinoma

• Authors : Yusuke Matoba; Dominique T. Zarrella; Venkatesh Pooladanda

Subjects: Galectin 3; Galectins; Blood Proteins

• Source: Br J Cancer

Record details

Galectin -3 拮抗剂改良柑橘果胶对肺动脉高压 大鼠的作用.

• Authors : 罗辉¹; 余再新²; 赵林³

• Source: Guangdong Medical Journal. 2024, Vol. 45 Issue 4, p419-424. 6p.

Record details

Salivary Galectin 3 Levels in Schizophrenia Patients

• Authors : Saba, Shoukat; Humaira Fayyaz, Khan; Muhammad, Kashif

Subjects: Inflammation; Cross-Sectional Studies; Galectin 3

• Source: Journal of the College of Physicians and Surgeons Pakistan. 34:202-205

Record details

Determination of Salivary Soluble Urokinase Plasminogen Activator Receptor (SuPAR), Hypoxia-inducible Factor-1 Alpha (HIF-1α), E-cadherin, Galectin 3, IL-4, IL-10 and TNF-α Levels in Individuals With Different Degrees of Periodontal Disease

• Authors : İsmail Taşdemir, Assistant professor

• Source: Determination of Salivary Soluble Urokinase Plasminogen Activator Receptor (SuPAR), Hypoxia-inducible Factor-1 Alpha (HIF-1α), E-cadherin, Galectin

Record details

Emerging role of galectin 3 in neuroinflammation and neurodegeneration

• Authors : Brian M. Lozinski; Khanh Ta; Yifei Dong

Subjects: 0301 basic medicine; 03 medical and health sciences; alzheimer's disease

• Source: Neural Regen ResNeural Regeneration Research, Vol 19, Iss 9, Pp 2004-2009 (2024)

Record details

Galectin-3 inhibition ameliorates hepatic steatosis in a multilineage 3D spheroid model.

• Authors : Sedda F; Unit of Oncology and Molecular Pathology, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.; Caddeo A

Subjects: Galectin 3*/Galectin 3*/Galectin 3*/antagonists & inhibitors ; Galectin 3*/Galectin 3*/Galectin 3*/metabolism ; Galectin 3*/Galectin 3*/Galectin 3*/genetics

• Source: PloS one [PLoS One] 2025 Jul 03; Vol. 20 (7), pp. e0326373. Date of Electronic Publication: 2025 Jul 03 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Galectin-3-Insights from Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.

• Authors : Grewal T; School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2006, Australia.; Tews HC

Subjects: Cholangitis, Sclerosing*/Cholangitis, Sclerosing*/Cholangitis, Sclerosing*/metabolism ; Cholangitis, Sclerosing*/Cholangitis, Sclerosing*/Cholangitis, Sclerosing*/pathology ; Inflammatory Bowel Diseases*/Inflammatory Bowel Diseases*/Inflammatory Bowel Diseases*/metabolism

• Source: International journal of molecular sciences [Int J Mol Sci] 2025 Jun 25; Vol. 26 (13). Date of Electronic Publication: 2025 Jun 25.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Serum sICAM-1 and Galectin-3 Levels in Diabetic Patients with COVID-19.

• Authors : Karahan B; Department of Internal Medicine, Erzurum Regional Training and Research Hospital, Erzurum 25240, Türkiye.; Binici DN

Subjects: COVID-19*/COVID-19*/COVID-19*/blood ; COVID-19*/COVID-19*/COVID-19*/diagnosis ; COVID-19*/COVID-19*/COVID-19*/complications

• Source: Viruses [Viruses] 2025 Jul 17; Vol. 17 (7). Date of Electronic Publication: 2025 Jul 17.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

Record details